ABSTRACT
Objective To observe the clinical efficacy of intradermal needle plus Chinese medication in treating post-stroke insomnia due to liver depression and spleen deficiency.Method A hundred patients with post-stoke insomnia due to liver depression and spleen deficiency were randomized into a treatment group and a control group, 50 cases each. The control group was intervened by oral administration of Zolpidem tartrate tablets, based on which, the treatment group was intervened by intradermal needle plus Chinese medication. The total score and component scores (sleep quality, sleep latency, sleep duration, sleep efficiency, sleep disturbance, sleeping pills, daytime dysfunction) of Pittsburgh Sleep Quality Index (PSQI), National Institute of Health Stroke Scale (NIHSS) and traditional Chinese medicine (TCM) symptom score were observed before and after the treatment for the two groups, and the clinical efficacies were also compared.Result The total effective rate was 88.0％ in the treatment group versus 70.0％ in the control group, and the between-group difference was statistically significant (P<0.05). After the treatment, the total and component scores of PSQI, NIHSS scores and TCM symptom scores were significantly changed in both groups (P<0.05). The total and component scores of PSQI, NIHSS score and TCM symptom score in the treatment group were significantly different from those in the control group after the intervention (P<0.05).Conclusion Intradermal needle plus Chinese medication can produce a significant efficacy in treating post-stroke insomnia due to liver depression and spleen deficiency.